Mark Barrett

Head of Business Development & Licensing
Business Development
sanofi genzyme
United States of America

Business Expert Immunology
Biography

He was completed his M.B.A., University of California, Berkeley - Walter A. Haas School of Business and from B.S., Biology, Duke University. He is working as Vice President and Head of Global Rare Diseases Strategy & Business Development, Genzyme, Transaction Leader, Johnson & Johnson, Senior Director, Business Development & New Ventures, Johnson & Johnson and Director, Business Development, Johnson & Johnson.  

Research Intrest

 Mark Barrett is responsible for identifying, leading, and executing global business development and corporate-level strategic initiatives. Mark leads the effort to build upon Genzyme’s long legacy of partnering and acquiring external innovation to expand Genzyme’s portfolio and pipeline.